NioCorp Developments Ltd Common Stock (NB) had the highest return between March 1, 2023 and April 30, 2023 by a US stock with a market cap of $200M+, returning 652,122.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
NioCorp Developments Ltd Common Stock (NB) | 3/1/2023 - 4/30/2023 | 652,122.22% |
Terawulf (WULF) | 3/1/2023 - 4/30/2023 | 173.85% |
Pulse Biosciences (PLSE) | 3/1/2023 - 4/30/2023 | 143.94% |
WW International, Inc Common Stock (WW) | 3/1/2023 - 4/30/2023 | 127.52% |
American Coastal Insurance (ACIC) | 3/1/2023 - 4/30/2023 | 117.36% |
Immuneering (IMRX) | 3/1/2023 - 4/30/2023 | 110.75% |
Viking Therapeutics (VKTX) | 3/1/2023 - 4/30/2023 | 93.55% |
Riot Blockchain (RIOT) | 3/1/2023 - 4/30/2023 | 87.46% |
Eyepoint Pharmaceuticals (EYPT) | 3/1/2023 - 4/30/2023 | 86.9% |
Sophia Genetics (SOPH) | 3/1/2023 - 4/30/2023 | 86.15% |
Tenaya Therapeutics (TNYA) | 3/1/2023 - 4/30/2023 | 73.13% |
Neurogene (NGNE) | 3/1/2023 - 4/30/2023 | 72% |
Gold Fields Ltd ADR (GFI) | 3/1/2023 - 4/30/2023 | 71.29% |
Arlo Technologies (ARLO) | 3/1/2023 - 4/30/2023 | 69.47% |
Perspective Therapeutics (CATX) | 3/1/2023 - 4/30/2023 | 67.57% |
Xeris Pharmaceuticals (XERS) | 3/1/2023 - 4/30/2023 | 66.18% |
ThredUp (TDUP) | 3/1/2023 - 4/30/2023 | 66.04% |
Aquestive Therapeutics (AQST) | 3/1/2023 - 4/30/2023 | 65.58% |
Arcturus Therapeutics (ARCT) | 3/1/2023 - 4/30/2023 | 65.14% |
Soleno Therapeutics (SLNO) | 3/1/2023 - 4/30/2023 | 64.39% |
Burford Capital (BUR) | 3/1/2023 - 4/30/2023 | 63.04% |
Crawford (CRD.A) | 3/1/2023 - 4/30/2023 | 61.83% |
Symbotic (SYM) | 3/1/2023 - 4/30/2023 | 61.46% |
Lifestance Health (LFST) | 3/1/2023 - 4/30/2023 | 58.87% |
AngloGold Ashanti (AU) | 3/1/2023 - 4/30/2023 | 57.4% |
